These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29915524)

  • 61. Moderate Levels of Pre-Treatment HIV-1 Antiretroviral Drug Resistance Detected in the First South African National Survey.
    Steegen K; Carmona S; Bronze M; Papathanasopoulos MA; van Zyl G; Goedhals D; MacLeod W; Sanne I; Stevens WS
    PLoS One; 2016; 11(12):e0166305. PubMed ID: 27907009
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prevalence of integrase inhibitor resistance mutations in Austrian patients recently diagnosed with HIV from 2008 to 2013.
    Zoufaly A; Kraft C; Schmidbauer C; Puchhammer-Stoeckl E
    Infection; 2017 Apr; 45(2):165-170. PubMed ID: 27530391
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mutations in the HIV-1 3'-Polypurine Tract and Integrase Strand Transfer Inhibitor Resistance.
    Wei Y; Sluis-Cremer N
    Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33722887
    [No Abstract]   [Full Text] [Related]  

  • 64. Resistance to HIV-1 integrase inhibitors: A structural perspective.
    Mouscadet JF; Delelis O; Marcelin AG; Tchertanov L
    Drug Resist Updat; 2010; 13(4-5):139-50. PubMed ID: 20570551
    [TBL] [Abstract][Full Text] [Related]  

  • 65. New antiretroviral agent use affects prevalence of HIV drug resistance in clinical care populations.
    Davy-Mendez T; Eron JJ; Brunet L; Zakharova O; Dennis AM; Napravnik S
    AIDS; 2018 Nov; 32(17):2593-2603. PubMed ID: 30134298
    [TBL] [Abstract][Full Text] [Related]  

  • 66. HIV-1 integrase polymorphisms are associated with prior antiretroviral drug exposure.
    van Hal SJ; Herring B; Deris Z; Wang B; Saksena NK; Dwyer DE
    Retrovirology; 2009 Feb; 6():12. PubMed ID: 19203393
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prevalence of resistance mutations associated with integrase inhibitors in therapy-naive HIV-positive patients in Hungary.
    Áy É; Pocskay Á; Lakatos B; Szlávik J; Mezei M; Minárovits J
    Acta Microbiol Immunol Hung; 2021 Jun; 68(2):87-91. PubMed ID: 34125695
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Usefulness of Integrase resistance testing in proviral HIV-1 DNA in patients with Raltegravir prior failure.
    Fernández-Caballero JÁ; Chueca N; Álvarez M; Mérida MD; López J; Sánchez JA; Vinuesa D; Martínez MÁ; Hernández J; García F
    BMC Infect Dis; 2016 May; 16():197. PubMed ID: 27177767
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Detection of drug resistance-associated mutations in human immunodeficiency virus type 1 integrase derived from drug-naive individuals in Surabaya, Indonesia.
    Kotaki T; Khairunisa SQ; Sukartiningrum SD; Witaningrum AM; Rusli M; Diansyah MN; Arfijanto MV; Rahayu RP; Nasronudin ; Kameoka M
    AIDS Res Hum Retroviruses; 2014 May; 30(5):489-92. PubMed ID: 24328535
    [TBL] [Abstract][Full Text] [Related]  

  • 70. HIV-1 genetic diversity and transmitted drug resistance to integrase strand transfer inhibitors among recently diagnosed adults in Porto Alegre, South Brazil.
    Nunes CC; Sita A; Mallmann L; Birlem GE; de Mattos LG; Da Silva DH; Furlanetto KO; Hansen AW; De Almeida PR; Fleck JD; Spilki FR; de Matos Almeida SE; Weber MN
    J Antimicrob Chemother; 2022 Nov; 77(12):3510-3514. PubMed ID: 36272141
    [TBL] [Abstract][Full Text] [Related]  

  • 71. HIV-1 drug resistance and genetic diversity in a cohort of people with HIV-1 in Nigeria.
    Oluniyi PE; Ajogbasile FV; Zhou S; Fred-Akintunwa I; Polyak CS; Ake JA; Tovanabutra S; Iroezindu M; Rolland M; Happi CT
    AIDS; 2022 Jan; 36(1):137-146. PubMed ID: 34628443
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Analysis of HIV Integrase Resistance in Black Men Who Have Sex with Men in the United States.
    Chen I; Zhang Y; Cummings V; Cloherty GA; Connor M; Beauchamp G; Griffith S; Rose S; Gallant J; Scott HM; Shoptaw S; Del Rio C; Kuo I; Mannheimer S; Tieu HV; Hurt CB; Fields SD; Wheeler DP; Mayer KH; Koblin BA; Eshleman SH
    AIDS Res Hum Retroviruses; 2017 Jul; 33(7):745-748. PubMed ID: 28384058
    [TBL] [Abstract][Full Text] [Related]  

  • 73. High prevalence of integrase mutation L74I in West African HIV-1 subtypes prior to integrase inhibitor treatment.
    El Bouzidi K; Kemp SA; Datir RP; Murtala-Ibrahim F; Aliyu A; Kwaghe V; Frampton D; Roy S; Breuer J; Sabin CA; Ogbanufe O; Charurat ME; Bonsall D; Golubchik T; Fraser C; Dakum P; Ndembi N; Gupta RK
    J Antimicrob Chemother; 2020 Jun; 75(6):1575-1579. PubMed ID: 32105319
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An HIV-1 integrase genotype assay for the detection of drug resistance mutations.
    Hearps AC; Greengrass V; Hoy J; Crowe SM
    Sex Health; 2009 Dec; 6(4):305-9. PubMed ID: 19917199
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Differential effects of the G118R, H51Y, and E138K resistance substitutions in different subtypes of HIV integrase.
    Quashie PK; Oliviera M; Veres T; Osman N; Han YS; Hassounah S; Lie Y; Huang W; Mesplède T; Wainberg MA
    J Virol; 2015 Mar; 89(6):3163-75. PubMed ID: 25552724
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Marked decrease in acquired resistance to antiretrovirals in latest years in Italy.
    Lai A; Franzetti M; Bergna A; Saladini F; Bruzzone B; Di Giambenedetto S; Di Biagio A; Lo Caputo S; Santoro MM; Maggiolo F; Parisi SG; Rusconi S; Gianotti N; Balotta C
    Clin Microbiol Infect; 2021 Jul; 27(7):1038.e1-1038.e6. PubMed ID: 32979570
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
    Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
    Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Detecting primary drug-resistant mutations in Korean HIV patients using ultradeep pyrosequencing.
    Cho MC; Park CW; Park BG; Oh HB; Choi SH; Choi SE; Cho NS
    J Virol Methods; 2016 Aug; 234():115-22. PubMed ID: 27109046
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evolution of HIV integrase resistance mutations.
    Quashie PK; Mesplède T; Wainberg MA
    Curr Opin Infect Dis; 2013 Feb; 26(1):43-9. PubMed ID: 23242340
    [TBL] [Abstract][Full Text] [Related]  

  • 80. HIV-1 non-B resistance mutations and natural polymorphisms to integrase strand transfer inhibitors in recently diagnosed patients in Gabon, Central Africa.
    Engone-Ondo JD; Bignoumba M; Boundzanga Moussavou P; Gafou A; Diane A; Yangawagou LM; Kassa Kassa RF; Onanga R; Mouinga-Ondémé A; Aghokeng AF
    J Antimicrob Chemother; 2022 Jun; 77(7):2035-2037. PubMed ID: 35474382
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.